Previous studies on the mode of action of various colicins have revealed two major features of colicin action (7, 8, 9) . First, apparently a single colicin particle is enough to kill one sensitive Escherichia coli cell, and the colicin particle stays at the receptor site and acts from there. Second, different colicins exert different biochemical effects on sensitive cells; i.e., colicin E2 causes DNA degradation, colicin E3 inhibits only protein synthesis, and colicins K and El inhibit all macromolecular synthesis, presumably through inhibition of oxidative phosphorylation.
Previous studies on the mode of action of various colicins have revealed two major features of colicin action (7, 8, 9) . First, apparently a single colicin particle is enough to kill one sensitive Escherichia coli cell, and the colicin particle stays at the receptor site and acts from there. Second, different colicins exert different biochemical effects on sensitive cells; i.e., colicin E2 causes DNA degradation, colicin E3 inhibits only protein synthesis, and colicins K and El inhibit all macromolecular synthesis, presumably through inhibition of oxidative phosphorylation.
The conclusion that the colicin stays at the receptor site and affects the biochemical targets from there was first obtained indirectly from the reversibility of colicin action by treatment with trypsin (10) . To test this conclusion more directly, we prepared radioactive colicins and studied their interaction with sensitive E. coli cells. The availability of these radioactive colicins enabled us to study several other questions. Colicins in the E group (El, E2, and E3) have been thought to have a common receptor (1) . Yet, their apparent modes of action are entirely different. The conclusion about the common receptor for the colicin E group came only from an analysis of mutants resistant to a colicin in the E group. The possibility has remained that the receptors are different from each other, but involve a common compound which the resistant mutants fail to synthesize. This problem, the identity of receptor for E group colicins, has also been studied conveniently by the use of radioactive purified colicins.
The third problem which has been studied with the radioactive colicin preparation is the problem of adsorption of colicin to the homologous colicinogenic immune cells. Immune cells are resistant to the killing action of the homologous colicins, but retain receptors, as evidenced by the sensitivity of these immune cells to other colicins or to phages in the same group (1) . However, the actual adsorption of colicin to immune cells was demonstrated unequivocally only by using heatkilled trypsin-treated cells (9) . Our previous attempts to demonstrate the adsorption of colicin E2 to intact viable E2 colicinogenic cells did not give a clear answer, mainly because of the high endogenous colicin production by intact colicinogenic cells. The use of radioactive purified colicin has made the direct experimental test of this problem easier.
The experimental results obtained by use of radioactive colicins have generally confirmed the conclusions deduced previously through the indirect experiments.
MATERIALS AND METHODS Organisms. Streptomycin -resistant derivative W31lOSmr of E. coli K-12 strain W3110 was used as a strain sensitive to colicins E2 and E3. Colicin E2 factor [originally derived from the Shigella sonnei strain P9 of Fredericq, i.e., col E2-P9 according to the nomenclature of Lewis and Stocker (4) ] was introduced into this sensitive strain from Salmonella typhimurium LT2 cys D36 (E2) by the method described by Stocker, Smith, and Ozeki (11) . The resultant E2 colicinogenic strain, 52, was used as a colicinogenic strain for preparing both radioactive and nonradioactive colicin E2 and for an adsorption experiment. This strain is resistant (immune) to colicin E2, but sensitive to colicin El, colicin E3, and phage BF23. Mutant strains ED11 and ED15 were isolated from the E2 colicinogenic strain 52 after treatment with N-methyl-N'-nitro-N-nitrosoguanidine. These mutants are defective in colicin production, but retain the immunity to E2. E. coli strain CA38 which is colicinogenic for both E3 and I (2) was obtained from H. Ozeki and was used for preparing both radioactive and nonradioactive colicin E3. A mutant, ER343, derived from W3110Smr was used as a resistant strain which is resistant to El, E2, E3, and phage BF23. Chemicals. Trypsin and trypsin inhibitor (soybean) were obtained from Sigma Chemical Co., St. Louis,
Mo.
Media. The following media were used. TB medium contained 1.3% tryptone (Difco) and 0.7% NaCl. Tris-S solution contained 0.1 M tris(hydroxymethyl)-aminomethane (Tris) buffer (pH 7.4), 0.08 M NaCl, 0.02 M KCI, 6.4 X 10-4 M KH2PO4, 1.6 X 10-4 M Na2SO4, 10-3 M MgCl,, 10-4 M CaC12, and 2 X 10-6 M FeCl8. Tris-glucose-Casamino Acids medium was Tris-S fortified with glucose (0.2%) plus 0.5% Vitamin Free Casamino Acids (Difco). M9 consisted of 0.7% Na2HPO4, 0.3% KH2PO4, 0.1% NH4Cl, 10-4 M MgSO4, 10-6M FeCI3, and 0.4% glucose. M9-Casamino Acids medium was M9 fortified with Casamino Acids (0.1%).
Assay of the killing activity of colicins. Two assay methods were used. The first method was a "spot test." A 0.01-ml amount of suitably diluted sample of colicin was spotted on the surface of a nutrient agar plate freshly seeded with 2 X 108 stationary-phase cells of W3110Smr in 2.5 ml of soft nutrient agar.
The colicin titer (called "units" in this paper) was arbitrarily defined as the highest dilution which gave a clear inhibition zone. The second method was the determination of the number of "killing particles" present in the sample by measuring the fraction of survivors after incubation of washed cells of W3110Smr with various concentrations of colicins (7, 8) . This second method was more accurate, and is referred to as the "standard method" in this paper. The number of "killing particles" thus estimated may or may not be equal to the actual number of active colicin molecules (see below). To avoid misunderstanding about this point, the term "killing units" will be used in this paper instead of "killing particles," which was used in our previous papers.
Preparation ofradioactive colicins E2 and E3. Initial attempts to obtain a radioactive E2 with a high specific activity by the tritium gas exposure method failed because of breakdown of the E2 during tritiation. A biological method of preparation was therefore adopted. Cells of the E2 colicinogenic strain, 52, were grown to a concentration of 5 X 108 per milliliter in M9-Casamino Acids medium, harvested, washed once, suspended in M9 (5 X 108 per milliliter), and shaken for 15 min at 37 C. A 1-ml amount of this culture was mixed with 2 ml of M9 solution containing 1 mc of Hs-leucine (5,000 mc/mmole, New England Nuclear Corp., Boston, Mass.). Mitomycin C (0.2 ,ug/ml) was added to the culture, and the culture was shaken for 4 hr at 37 C. Cells were then collected by centrifugation. Colicin E2 was extracted from the cells and purified by the method developed by Helinski (manuscript in preparation). Carrier albumin (1 mg/ml) was added to prevent a possible inactivation of colicin in a dilute solution, whenever it was necessary. The last step of the purification was chromatography on a hydroxylapatite column. The elution pattern of the chromatography is shown in Fig. 1 . The frctions containing E2 activity were pooled, dialyzed against water, and lyophilized. Colicin E2 thus prepared was stable in the cold in a lyophilized state for at least several months.
C"4-labeled E2 was prepared in the same way except that 0.1 mc of C'4-Chlorella protein acid hydrolysate (8.6 mc/mmole of carbon, a gift from the Institute of Applied Microbiology, University of Tokyo) was used instead of H3-leucine.
H-labeled E3 was prepared in a similar way. E. coli strain CA38 was induced with mitomycin C to produce E3. The induced culture had a very high E3 activity, but very little colicin I activity. An elution pattern of the chromatography on a hydroxylapatite column is shown in Fig. 2 . The fractions containing E3 were pooled, dialyzed against water, and lyophilized. This preparation was found to contain a significant amount of radioactive materials which adsorbed to a resistant strain, ER343, and, therefore, was treated with washed cells of strain ER343 to remove such radioactive materials. The resultant preparation was used within a few days.
Preparation ofnonradioactive E2 and E3. Nonradioactive E2 was prepared on a larger scale by the method of Helinski (in preparation). The method gives a preparation which is pure as judged by ordinary 
RESULTS
Purity of radioactive colicine. The elution patterns of hydroxylapatite chromatography of both E2 and E3 ( Fig. 1 and 2 ) showed that the peak of radioactivity curve coincided with the peak of the colicin activity curve. Therefore, the material was assumed to be reasonably pure.
(Lack of exact proportionality between killing activity and radioactivity may be mostly due to the inaccuracy involved in the biological assay of the killing activity.) As an additional check on the purity, the adsorption of the radioactive material in the E2 preparations to both sensitive and resistant cells was tested. As shown in Table 1 , about 80 to 90% of the total radioactivity was adsorbed to sensitive cells, whereas only a very small fraction (less than 6%) was adsorbed to resistant cells.
In view of the good chromatographic pattern of the radioactive material ( Fig. 1) , and the purity of the preparation obtained by the similar method (Helinski, in preparation), the unadsorbed radioactive material, which is 10 to 20% of the total radioactivity, might be a denatured colicin protein which cannot be adsorbed by the sensitive cells but retains chromatographic properties identical to those of active colicin. As already described, the radioactive E3 preparation obtained after hydroxylapatite chromatography contained a significant amount of radioactive materials which adsorbed to resistant cells. The preparation obtained after the adsorption with resistant cells showed that 60% of total radioactivity was adsorbed to sensitive cells, and only 5 sistant cells. Although the problem of a small fraction of radioactive contaminants was unsolved, especially with the preparation of radioactive E3, the fraction which was adsorbed by resistant cells was very small. Therefore, it was concluded that the colicin preparations could be used for the experiments described in this paper, which were concerned with the radioactive material adsorbed by sensitive cells. Kinetics of adsorption. Radioactive colicin E2 was mixed with sensitive cells at a cellular concentration of 4 X 108 per milliliter, and the amount of radioactive material adsorbed at various times was measured. Figure 3 shows the results. Adsorption was found to be practically complete at 37 C within 10 min. However, adsorption was slower at 0 C. Accordingly, the incubation time selected to assure a complete adsorption was 45 min at 37 C and 2 hr at 0 C, in most of the experiments described in this paper.
Number ofcolicin particles that can be adsorbed by a sensitive cell. One can estimate the amount of colicin adsorbed to cells by first mixing various amounts of colicins with sensitive cells and then subtracting the amount of colicin left in the solution from the total amount initially added.
By such a method Mayr-Harting (6) showed that under her experimental conditions a sensitive E. coli cell can adsorb a maximum of 11 killing units of E2. Under our experimental conditions, we found little killing activity left in the supernatant fluid up to a ratio of 20 to 30 killing units of E2 or E3 per bacterial cell (see Fig. 7 ). Therefore, the minimal number of units of colicins that can be adsorbed by a bacterium is about 20 to 30 for both E2 and E3 under the present experimental conditions. However, the above method assumes that the sensitive cells do not have a mechanism which inactivates colicin and leaves it in the medium. If such a mechanism exists, the value would be higher than the difficult, since the adsorbed amount, which can be estimated only by subtraction of the unadsorbed from the total, becomes a very small fraction of the total. Thus, a sensitive cell might adsorb more colicin particles at a higher concentration of colicin than those estimated by the method described above.
By the use of radioactive colicin, one can directly measure the amount of colicin adsorbed to a cell. Figure 4 shows Table 2 . It is clear that most of the radioactive material was with the cell envelope fraction (cell wall and cell membrane fragments), and very little free radioactive colicin (less than 1 or 2% of the total) was found in the soluble fraction.
The small amount of radioactive colicin (8%) found in the ribosome fraction could be explained by the contamination of cell wall or membrane fragments in this fraction. Thus, the result agrees with the conclusion that colicin stays at the receptor site.
The treatment of C14-E2-pretreated cells with the excess cold E2 before the cell disruption was done to cover any unoccupied receptor with the cold E2, and thus to prevent a possible reattachment of the hypothetical internal free C14-E2 to the unoccupied receptor after the disruption of the cells. The experiment was also done without such cold E2 treatment, and essentially the same results were obtained; most of the radioactivity was found in the cell envelope fraction, and very little in the soluble fraction. The deoxyribonuclease treatment prior to the differential centrifugation degraded nearly all the deoxyribonucleic acid (DNA) to oligonucleotides which appeared in the soluble fraction after the differential centrifugation. Therefore, it was concluded that colicin E2 does not attach to DNA, a biochemical target. However, this experiment by itself does not exclude the possibility that a small fragment of DNA remains attached to the membrane, and the radioactive E2 makes a complex with this DNA fragment.
Digestion of adsorbed radioactive E2 with trypsin after attachment to sensitive cells. Since the strongest evidence concerning the state of colicins after adsorption to sensitive cells is the reversibility of colicin action with trypsin treatment, our previous reasoning that the reversal is due to digestion of the colicin was tested with radioactive colicin E2. Washed cells were treated with radioactive E2 at a multiplicity of 8 at 37 C for 5 min. The cells were then centrifuged, washed, resuspended, and divided into three tubes. Trypsin was then added to one tube (time zero). The second tube received the trypsin at 30 min, and the third tube served as a control. The addition of trypsin at the early time (5 min after E2 addition in this case) usually caused an increase of survivors from the order of 10-4 to the order of 10-1 of the original viable bacteria. This is understandable, since DNA degradation does not proceed very extensively by 5 min. As shown in Fig. 5 , the trypsin gradually removed radioactive E2 from cells, and only 40% of total initial radioactivity remained after 3 hr of incubation. When trypsin was added at 30 min, the increase in survivors was usually rather low, since the irreversible breakdown of bacterial DNA took place by 30 min (see Fig. 6b ). The transition from the reversible stage to the irreversible stage is not due to the penetration of E2 into the cytoplasm; the removal of radioactive colicin from treated cells was found to be as efficient as when trypsin was added at time zero. These results agree with the previous conclusion that trypsin reversal (2 X 108 per milliliter of strain W31OSmr were treated with radioactive E2 at a multiplicity ofabout 8 for 5 min at 37 C. Cells were then cooled by mixing with 2 volumes of cold buffer, centrifuged in the cold, washed, andresuspended in Tris-glucose-Casamino Acids medium containing chloramphenicol (CM, 50 g/ml) at a concentration of2 X 106 per milliliter. Radioactive cells were divided into three tubes and incubated at 37 C. Theefirst and the second samples were treated with trypsin (500 pug/ml) at time zero and at 60 min, respectively. The third sample was not treated with trypsin. At times indicated, a 1-ml sample was withdrawn and diluted with 2 ml of Tris-S containing trypsin Inhibitor (50) pg/ml).
Cells were then separatedfrom the medium by centnifugation, treated with trichloroacetic acid (5%0), and collected on membrane filters. Their radioactivty was then measured.
capacity of E2-pretreated cells to adsorb further colicin E2. This possibility was tested experimentally. Washed sensitive cells were first treated with an excess of nonradioactive colicin at 37 C for 5 min. Cells were then collected by centrifugation, washed, and resuspended in medium containing chloramphenicol (CM). Trypsin was added either at time zero or at 60 min. At intervals, samples were taken, and the capacity of the trypsin-treated cells to adsorb radioactive E2 was determined (after the treatment of cells with trypsin inhibitor), and compared with that of control cells without trypsin (Fig. 6 a) . Simultaneously, colony formers were measured (Fig. 6 b) . It is clear that as much as 50% of the total initial capacity was recovered by trypsin treatment in both cases (trypsin added at time zero and at 60 min). These experimental results show that the majority of E2 stays at the receptor site, and trypsin digesLs E2 and removes it from the receptor site. Thus, several experimental results support very strongly our previous conclusion that colicin stays at the receptor site and acts from there.
Competition between colicins E2 and E3 for a receptor site. As described in the introduction, colicins E2 and E3 have been thought to have a common receptor. This was tested directly by use of radioactive colicin. In the first experiment, sensitive cells were treated with various amounts of nonradioactive colicin E3 at 0 C for 60 min, and were then centrifuged. Unadsorbed colicin E3 was assayed by analyzing the killing activity of the supernatant fluid after centrifugation. Washed cells were then treated with an excess amount of radioactive E2, and the amount adsorbed to the cells was assayed (Fig. 7 a) .
In the second experiment, cells were first treated with nonradioactive E2, and the adsorption of radioactive E3 was then examined in the same way (Fig. 7 b) . Adsorption of the first colicin was performed at 0 C to minimize the possibility that the adsorbed colicin exerts some (unknown) biochemical effect on the membrane, causing a decreased efficiency of adsorption at other unoccupied receptor sites. However, preadsorption at 37 C instead of 0 C gave essentially the same results. As can be seen, the decrease in the amount of the second radioactive colicin adsorbed to the cells was found to be approximately proportional to the amount of the nonradioactive colicin added first, until the latter approached a saturation point, that is, 20 to 30 killing units per cell. The 1, 2, 3 ). Cells were then collected by centrifugation, washed, resuspended in Tris-glucose-Casamino Acids medium containing CM (50 g/ml), and were then incubated at 37 C. Trypsin (500 pg/ml) was added either at 0 min (curves 2, 5) or at 60 min (curves 3, 6). At intervals, both survivors (b) and E2-adsorption capacity (a) were determined. E2-adsorption capacity was measured as follows. Samples were centrifuged. Cells were washed and resuspended in buffer containing trypsin inhibitor (I mg/ml). After 5 min at 37 C, cells were again centrifuged, washed, and resuspended in buffer (2 X 108 per milliliter). H3-labeled colicin E2 was then added at the ratio ofabout 30 killing units to one cell and incubated at 0 Cfor 120 min. Radioactive colicins adsorbed to the cell were then determined by centrifuging cells and measuring their radioactivity.
different. The specificity in biochemical action cannot be accounted for by the specificity in adsorption.
It was observed that a significant amount of radioactive material (about 20% of the total) was adsorbed even though the cells were pretreated with the excess cold colicin. The amount is too high to be due to a nonspecific adsorption of radioactive materials. This might be due to To minimize the adsorption of spontaneously induced colicins to the noninduced majority of cells during the growth, colicinogenic cells were grown in the presence of trypsin. The resultant cells were centrifuged, washed, and then treated with radioactive colicins. As shown in Fig. 8 a, such colicinogenic cells adsorbed radioactive colicin to the same extent as did control sensitive cells. Simultaneous assay of number of survivors (Fig. 8b) , showed that such colicinogenic cells were resistant, whereas the sensitive cells both with and without trypsin pretreatment were killed. Thus, it was clearly established that E2-colicinogenic cells adsorb homologous colicin E2, and yet are resistant to this colicin.
The conclusion that the colicinogenic immune cells have the capacity to adsorb homologous colicin is also supported by experiments with the mutants ED11 and ED15 derived from the colicinogenic strain 52 which are defective in colicin production; the mutants produce very little colicin, but retain the immunity. The culture of these mutants contains no colicin, and, therefore, the adsorption of colicin E2 to these defective mutants could be tested more directly without using radioactive E2 and without trypsin pretreatment.
Cells of EDi1 and ED15 were grown in the absence of trypsin, washed, and then mixed with nonradioactive E2 at a multiplicity of about 2. After the incubation at 37 C for 30 min, the cells were removed by centrifugation, and the colicin activity left in the supernatant fluid was assayed by the spot test. Less than 3 % of the total activity initially added was found in the supernatant fluid. The adsorption of E2 to these mutants was also shown by use of radioactive E2. Thus, these defective colicinogenic cells adsorb E2, and yet they are resistant to E2.
DIsCUSSION
The killing action of most colicins is a singlehit process (3, 7) . This means that the killing does not require a cooperative function of several particles; that is, a single particle causes, with a certain probability, the death of a sensitive cell. The actual amount of protein corresponding to a single killing unit can be calculated from the experimental curves. The amount of colicin giving 37% survivor corresponds to a multiplicity of 1 killing unit of colicin per sensitive cell used. With the use of a molecular weight for E2 of 60,000, which Helinski obtained (personal communication), and assuming that our E2 preparation is pure, it is calculated that one killing unit corresponds to about 100 molecules. This value ranged between 40 and 300 depending on experimental conditions and preparations (Maeda and Nomura, unpublished data).
The deviation from the value one is either due to inactive particles contained in the preparation or to the low probability (1%) of a successful killing action per adsorbed particle, or to both. The second explanation includes the possibility of heterogeneity of receptors. Since the change of assay conditions (e.g., temperature, the physiological state of sensitive cells) was found to affect the slope of the killing curve, the second explanation accounts for at least a part of the deviation from one. As an extreme example, certain mutants show near complete resistance at 42 C and a sensitivity comparable to the wild-type strain at 30 C (Nomura, unpublished data). Since adsorption has been shown to be normal at 42 C, the probability of a successful killing action per adsorbed particle varies enormously with this mutant, that is, from 1% to less than 103%, depending on the temperature.
If the second explanation is a major one, that is, if our radioactive E2 preparation consists mostly of more or less homogeneous potentially active molecules with a low probability (about 1%) of successful killing, the experiments described in the present paper give unequivocal answers to the questions asked as to the state of the active colicin molecules after the adsorption to cells, the relationship between the receptor sites for active E2 and E3 molecules, and the adsorption of active E2 molecules to the E2-colicinogenic immune cells. (It should be pointed out that the isotope experiment by itself does not exclude the possibility of penetration of a single "effective" molecule during the irreversible stage of killing. However, our previous demonstration that trypsin reverses colicin action, and that the reversal is not due to its action on cells, shows very strongly that colicin stays on the cell surface. The results of the present isotope experiments agree with the predictions from this conclusion and, therefore, strengthen our previous conclusion.) If, on the other hand, our E2 preparation consists of a minority (about 1%) of active molecules and a majority of "inactive" molecules, the present experiments cannot provide a definite proof of our previous conclusions obtained through the indirect experiments. However, the fact that the behavior of the bulk of 693 VOL. 91, 1966 on November 13, 2017 by guest http://jb.asm.org/ Downloaded from radioactive colicin agreed with that predicted from the results of the previous indirect experiments supports the previous conclusions very strongly, even though the problem of the possible majority of "inactive" molecules still exists.
The first major conclusion supported by the present study is that the colicin stays at the receptor site and acts from there. This implies that the primary action of colicin is on the cytoplasmic membrane. In this connection, the specificity of the biochemical action of different colicins suggests that bacterial cytoplasmic membrane is a mosaic, consisting of several specific parts, each of which has an important function, and that these functions can be inhibited individually by specific chemical stimuli initiated by specific colicins at the receptor site.
The second major conclusion supported by the present study is that there are some specific steps between adsorption and the target. Thus, the present study has established the following facts. (i) Colicins E2 and E3 share a common receptor, and yet their apparent modes of action are entirely different. The specificity in biochemical action cannot be accounted for by the specificity in adsorption. (ii) Immune cells adsorb a homologous colicin; that is, the immunity of colicinogenic cells does not depend on an alteration in the adsorption step. Since the immunity to E2 does not involve alteration in the properties of DNA, i.e., the final biochemical target of E2 (7), the altered component must participate in a step between adsorption and the target.
The significance of these conclusions has already been discussed in connection with the proposed mechanism of colicin action (8, 9 ; see also 5).
